Calumet Specialty Products focuses on specialty refining. Operations underpin the CLMT stock story
Calumet Specialty Products Partners (CLMT) is a U.S.-based refiner and producer of specialty petroleum products and fuels. The company's operations balance a niche specialty segment with a fuels segment, influencing its stock performance. Its master limited partnership structure means it distributes a significant portion of cash to unitholders, making strong cash generation and operational efficiency key to investor returns and distribution sustainability amidst volatile energy markets.
Precision Trading with Calumet Specialty Products Partners L.p. (CLMT) Risk Zones
This article analyzes Calumet Specialty Products Partners L.p. (CLMT) using AI models to provide precision trading strategies. It highlights a divergent sentiment, suggesting choppy conditions, and presents exceptional risk-reward setups. Three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—are offered for various risk profiles and holding periods, along with multi-timeframe signal analysis.
Precision Trading with Calumet Specialty Products Partners L.p. (CLMT) Risk Zones
This article from Stock Traders Daily provides a detailed AI-driven analysis for Calumet Specialty Products Partners L.p. (CLMT), highlighting a "mid-channel oscillation pattern" and divergent sentiment across various time horizons. It outlines three institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones, and presents a striking 38.6:1 risk-reward short setup. The analysis also includes multi-timeframe signal data for near-term, mid-term, and long-term perspectives.
Calumet Specialty Products Stock - Weekly review in the energy sector
Calumet Specialty Products (CLMT) closed a volatile week without fresh corporate news, with its stock ending at $32.68 on June 18, 2026. The company, which specializes in petroleum products and renewable fuels, is influenced by broader energy sector volatility, crude oil prices, and refinery margins. This week's performance focused on its trading relative to sector benchmarks rather than specific company catalysts, highlighting its unique position between traditional specialty refining and renewable fuels.
AYAL Capital Advisors Ltd Sells 221,645 Shares of Calumet, Inc. $CLMT
AYAL Capital Advisors Ltd reduced its stake in Calumet, Inc. (NASDAQ:CLMT) by 53.2% in the fourth quarter, selling 221,645 shares. Despite this, other major institutional investors like Vanguard Group Inc. and Marshall Wace LLP increased their positions. The article also details recent insider transactions and analyst ratings, with Calumet currently holding an average "Hold" rating from analysts.
Technical Reactions to CLMT Trends in Macro Strategies
This article analyzes Calumet Specialty Products Partners L.p. (NASDAQ: CLMT) trends using AI models, identifying a mid-channel oscillation pattern and a strong risk-reward setup. It outlines specific trading strategies (Position, Momentum Breakout, Risk Hedging) and provides multi-timeframe signal analysis, noting weak near-term sentiment but strong mid and long-term outlooks.
CLMT SEC Filings - Calumet 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Calumet (CLMT) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. It details recent filings such as The Heritage Group's amended 13D filing showing changes in beneficial ownership and gifts of shares, as well as multiple Form 4 filings regarding equity awards (Restricted Stock Units) to Calumet directors. The platform also offers AI-generated summaries, impact scoring, and sentiment analysis for each filing.
Calumet stock hits 52-week high at $36.97 By Investing.com
Calumet Specialty Products Partners, L.P. (CLMT) stock reached a new 52-week high of $36.97, reflecting a 172.94% increase over the past year and an 84% return in the last six months, with a market capitalization of $3.15 billion. Despite this, InvestingPro analysis suggests the stock may be overvalued and the company remains unprofitable, with analysts not anticipating profitability this year. The company recently reported a substantial earnings miss for Q1 2026, though revenue slightly exceeded expectations.
Calumet stock hits 52-week high at $36.97 By Investing.com
Calumet Specialty Products Partners, L.P. (CLMT) stock reached a new 52-week high of $36.97, reflecting a 172.94% increase over the past year and an 84% return in the last six months. Despite this strong performance and a market capitalization of $3.15 billion, InvestingPro analysis indicates the stock may be overvalued and the company remains unprofitable, with analysts not expecting profitability this year. This rise comes even after a significant EPS miss in Q1 2026, though revenue slightly exceeded expectations.
Trading the Move, Not the Narrative: (CLMT) Edition
This article analyzes Calumet Specialty Products Partners L.p. (NASDAQ: CLMT), indicating strong sentiment and a breakout that suggests higher levels. It provides three distinct AI-generated trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss levels, alongside multi-timeframe signal analysis for near-term, mid-term, and long-term horizons.
Trading the Move, Not the Narrative: (CLMT) Edition
This article provides an in-depth analysis of Calumet Specialty Products Partners L.p. (NASDAQ: CLMT), indicating strong sentiment and an ongoing breakout. It outlines three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored to different risk profiles. The analysis also includes multi-timeframe signal analysis with support and resistance levels.
Calumet (Nasdaq:CLMT) - Stock Analysis
Calumet (CLMT) is currently trading at US$37.37, with a market capitalization of US$3.1 billion, and is considered overvalued by analysts at 59.4% with a fair value of US$23.45. The company faces significant risks including negative shareholder equity and current unprofitability with no forecast for profitability in the next three years, despite having grown earnings by 10% annually over the last five years. Recent news highlights the completion of its Montana Renewables MaxSAF 150 expansion, expected to quadruple sustainable aviation fuel output, which is weighed against a major operational disruption at its Shreveport facility causing US$30 million in lost opportunity due to contamination.
Linscomb Wealth Inc. Sells 30,000 Shares of Calumet, Inc. $CLMT
Linscomb Wealth Inc. significantly reduced its stake in Calumet, Inc. (NASDAQ:CLMT) by 53.7% in the fourth quarter, selling 30,000 shares. This comes as Calumet reported a much wider-than-expected loss for the quarter, despite revenue slightly exceeding expectations. Analyst ratings for CLMT are mixed, with a consensus "Hold" rating, while insider selling by a major shareholder has also been noted.
PN Bakken: MDU, Calumet team up on 20,000 b/d refinery
MDU Resources Group Inc. and Calumet Specialty Products Partners L.P. have formed a joint venture, Dakota Prairie Refining LLC, to build and operate a 20,000 barrels per day diesel refinery in southwestern North Dakota. Construction is expected to begin this spring and take up to 20 months, employing about 100 people. This project aims to expand MDU Resources' midstream energy business and Calumet's diversification efforts, and is supported by North Dakota Governor Jack Dalrymple as a long-term economic and energy solution for the state.
Investor meetings on tap as Calumet heads to BofA energy credit event
Calumet (NASDAQ: CLMT) announced it will attend the Bank of America Energy and Power Credit Conference on June 4, 2026, to hold one-on-one investor meetings. The company, headquartered in Indianapolis, manufactures and markets specialty branded products and renewable fuels from twelve facilities across North America. This participation follows a trend of active investor outreach by Calumet, with recent market reactions to company news generally aligning with the sentiment of each announcement.
Calumet Specialty Products Partners L.P. to Attend Goldman Sachs Conference on May 28, 2026
Calumet Specialty Products Partners L.P. (CLMT) is scheduled to attend the Goldman Sachs Leverage Finance Conference on May 28, 2026. This announcement, powered by GeneOnline AI, indicates the company's participation in the significant financial event.
(CLMT) Volatility Zones as Tactical Triggers
This article provides an in-depth analysis of Calumet Specialty Products Partners L.p. (NASDAQ: CLMT), highlighted by a mid-channel oscillation pattern and a strong risk-reward short setup. It details positive near-term sentiment while noting a weak mid-term bias within a long-term strength context. The analysis also outlines specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis and AI-generated signals for support and resistance levels.
(CLMT) Volatility Zones as Tactical Triggers
This article analyzes Calumet Specialty Products Partners L.p. (NASDAQ: CLMT) using AI models to identify volatility zones and tactical triggers for trading. It presents three distinct strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, including near-term, mid-term, and long-term support and resistance levels. The analysis highlights a positive near-term sentiment while noting a mid-term weak bias within a context of long-term strength.
Calumet Q1 Earnings Call Highlights
Calumet (NASDAQ: CLMT) executives discussed their Q1 2026 earnings, highlighting strong margin conditions for both traditional and renewable fuels despite setbacks from a Shreveport facility downtime and planned work at Montana Renewables. The company achieved $50.1 million in adjusted EBITDA, slightly below the previous year, with significant contributions from its Montana Renewables segment and strategic price actions in Specialty Products and Solutions. Future plans include deleveraging and potentially monetizing Montana Renewables, especially after the MaxSAF project and improved RVO outlook.
Price-Driven Insight from (CLMT) for Rule-Based Strategy
This article provides a price-driven insight for Calumet Specialty Products Partners L.p. (CLMT), highlighting weak near-term sentiment despite strong mid and long-term signals. It outlines three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis emphasizes an exceptional risk-reward setup targeting a 14.2% gain against 0.3% risk.
Calumet (NASDAQ:CLMT) Issues Earnings Results
Calumet (NASDAQ:CLMT) reported Q1 2026 earnings per share of ($3.64), significantly missing analyst estimates of ($0.57), despite revenue of $1.03 billion slightly exceeding expectations and growing 3.6% year-over-year. The company cited an unexpected operational issue at its Shreveport plant, which caused substantial lost production and opportunity, but highlighted positive impacts from biofuel rules and improved fuels margins for its Montana Renewables segment. Following the earnings report, Calumet's stock declined by 7.3%, and insider activity showed a director selling shares in April.
Calumet Q1 Earnings Call Highlights
Calumet's Q1 2026 earnings call revealed a strategically pivotal period, despite first-quarter results not fully reflecting strong margin conditions due to downtime at its Shreveport facility and planned work at Montana Renewables. The company achieved $50.1 million in adjusted EBITDA, slightly below the previous year, influenced by an incident at Shreveport involving organic chlorides in the crude stream and temporary margin compression in Specialty Products and Solutions due to crude price spikes. Montana Renewables saw an increase in adjusted EBITDA, driven by the MaxSAF 150 expansion and an improved RVO outlook, with expectations of a significant shift towards sustainable aviation fuel production.
Calumet (NASDAQ:CLMT) Surprises With Q1 CY2026 Sales
Calumet (NASDAQ:CLMT) reported Q1 CY2026 sales of $1.03 billion, exceeding Wall Street expectations, though its GAAP loss of $3.64 per share and Adjusted EBITDA missed consensus estimates due to an unrealized loss for derivatives. The company highlighted a pivotal moment in its transformation and noted solid annualized revenue growth over the last five years, despite consistent negative free cash flow. The report suggests the latest quarter is one aspect of its business quality, which combined with valuation, can indicate if the stock is a buy.
(CLMT) Price Dynamics and Execution-Aware Positioning
This article analyzes Calumet Specialty Products Partners L.p. (NASDAQ: CLMT) using AI models, highlighting divergent sentiment across time horizons that suggests choppy conditions. It presents an exceptional short setup and outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored to different risk profiles, along with multi-timeframe signal analysis for support and resistance levels.
Calumet (CLMT) Projected to Post Earnings on Friday
Calumet (NASDAQ:CLMT) is projected to release its Q1 2026 earnings before market open on Friday, May 8th, with analysts expecting a loss of ($0.57) per share on $1.0011 billion in revenue. The company previously beat EPS estimates in the last quarter, reporting ($0.43) vs. consensus ($0.67). Institutional investors have adjusted their holdings, and analysts currently have a "Hold" consensus rating with a $30.50 price target on the stock.
Calumet, Inc. (NASDAQ:CLMT) Given Consensus Rating of "Hold" by Analysts
Calumet, Inc. (NASDAQ:CLMT) has received a consensus "Hold" rating from analysts, with an average one-year price target of $30.50. This mixed sentiment is despite the company beating its quarterly EPS estimates, reporting a loss of $0.43 against an estimated loss of $0.67, and showing a 9.4% year-over-year revenue increase to $1.04 billion. Recent insider activity includes a director selling over 3,300 shares, and institutional investors have made various adjustments to their holdings.
Why Calumet (CLMT) Shares Are Trading Lower Today
Shares of Calumet (NASDAQ:CLMT) fell 4.8% after Goldman Sachs downgraded the company's stock from Buy to Neutral, indicating a less optimistic short-term outlook. Despite the downgrade, Goldman Sachs increased their price target from $34 to $36. The stock has shown volatility, and while down today, it is up 59.8% year-to-date and has delivered significant returns over five years.
Calumet (NASDAQ:CLMT) Stock Price Down 6.2% - Should You Sell?
Calumet (NASDAQ:CLMT) stock dropped 6.2% to $30.75 on Friday after trading approximately 65% below its average daily volume, falling near its consensus target price. Analysts are divided on CLMT's outlook, with a consensus "Hold" rating and price targets ranging from $26 to $60. Despite exceeding Q4 EPS and revenue estimates, analysts project a negative EPS for the current year, while hedge funds have significantly increased their stakes in the company.
How many employees work at Calumet Specialty Prods?
Calumet Specialty Products Partners LP currently employs 1,683 individuals, indicating a year-over-year growth rate of -2.8%. The company produces ingredients for various products, from cosmetics to jet fuel, and operates across multiple locations. Revelio Labs provides detailed workforce intelligence data, including headcount trends, average salary, and job postings.
Calumet (NASDAQ:CLMT) Stock Passes Above 200 Day Moving Average - Time to Sell?
Calumet (NASDAQ:CLMT) stock has moved above its 200-day moving average, trading at $32.53, a notable technical breakout. Analyst opinions are mixed, with a consensus "Hold" rating and a target price of $30.17, although some analysts have significantly raised their price targets. Despite negative earnings, the company beat EPS estimates and saw a 9.4% increase in revenue.
Calumet to produce renewable diesel at Montana refinery
Calumet Specialty Products Partners announced in February 2021 its intention to produce renewable diesel at its Great Falls, Montana refinery. This move signifies the company's entry into the renewable fuels market and aligns with growing industry trends towards sustainable energy production. The original article is from February 2021, and this re-published piece from 2026 refers to that older announcement.
Calumet, Inc. (NASDAQ:CLMT) Receives Consensus Rating of "Hold" from Brokerages
Eight brokerage firms have issued a "Hold" consensus rating for Calumet, Inc. (NASDAQ:CLMT), with an average one-year price target of $30.17. The company recently reported Q4 EPS of -$0.43, outperforming estimates, and revenue of $1.04 billion, a 9.4% year-over-year increase. Despite some insider selling, institutional ownership in Calumet stands at 34.41%, with several funds increasing their stakes.
Calumet (NASDAQ:CLMT) Director Daniel Sajkowski Sells 3,310 Shares
Calumet Director Daniel Sajkowski sold 3,310 shares of the company's stock on April 1st for a total of $114,062.60, reducing his stake by 3.88%. This transaction comes as Calumet has shown strong Q4 earnings, beating analyst expectations, and has seen its stock price rally towards a 52-week high with increased analyst attention, despite facing some near-term operational risks from unplanned maintenance.
Calumet director Sajkowski sells $114k in shares By Investing.com
Calumet director Daniel J. Sajkowski sold 3,310 shares of common stock for a total of $114,062 on April 1, 2026. The transaction was executed under a Rule 10b5-1 trading plan. This sale occurred while CLMT stock is trading near its 52-week high, having delivered significant returns over the past year.
HC Wainwright Issues Positive Outlook for Calumet Earnings
HC Wainwright has issued a positive outlook for Calumet (NASDAQ:CLMT), increasing its 2026 quarterly EPS estimates and forecasting a return to profitability with FY2027 EPS of $1.07. The firm reiterated a "Buy" rating and a $60 price target, despite the street's consensus still predicting multi-quarter losses. The stock saw a 12% jump on the news, reflecting investor reaction to the upgraded forecasts.
H.C. Wainwright raises Calumet stock price target to $60 from $33 By Investing.com
H.C. Wainwright significantly increased its price target for Calumet Specialty Products Partners (CLMT) to $60 from $33, while maintaining a Buy rating. This adjustment reflects improved adjusted EBITDA projections for 2026 and 2027, driven by expectations of better pricing and demand for renewable fuels. Despite this bullish outlook, InvestingPro analysis suggests the stock might be overvalued, though the company has also been active in debt reduction and pre-selling sustainable aviation fuel (SAF).
Calumet (NASDAQ:CLMT) Given New $60.00 Price Target at HC Wainwright
HC Wainwright has raised its price target for Calumet (NASDAQ:CLMT) to $60.00 from $33.00, maintaining a "buy" rating and suggesting an 87% upside. This new target contributes to a mixed analyst consensus of "Hold" with an average target of $30.17. The oil and gas company recently surpassed EPS estimates and saw a 9.4% increase in revenue year-over-year.
H.C. Wainwright raises Calumet stock price target to $60 from $33
H.C. Wainwright significantly increased its price target for Calumet Specialty Products Partners (NASDAQ: CLMT) to $60 from $33, while maintaining a Buy rating. This adjustment is based on raised adjusted EBITDA projections for 2026 and 2027, driven by expected improvements in renewable fuel pricing and demand. Despite the bullish outlook, InvestingPro analysis suggests the stock might be overvalued at its current trading levels.
Adams Asset Advisors LLC Has $102.46 Million Stock Position in Calumet, Inc. $CLMT
Adams Asset Advisors LLC has a $102.46 million stock position in Calumet, Inc. (NASDAQ:CLMT), representing its second-largest holding and 13.5% of its portfolio, despite trimming its stake by 4.6% in Q4. Calumet reported a Q4 EPS of ($0.43), beating estimates, with revenue up 9.4% year-over-year. The stock currently trades around $32.06, and analysts maintain a mixed outlook with an average "Hold" rating, though Goldman Sachs raised its target to $34 with a "buy" rating.
$150M notes deal lets Calumet cut revolver borrowings now
Calumet (NASDAQ: CLMT) completed a private placement of $150 million aggregate principal amount of 9.75% Senior Notes due 2031, issued at 105% of par, generating net proceeds of approximately $154.9 million. The company intends to use these proceeds to immediately repay outstanding borrowings under its revolving credit facility. This transaction is part of Calumet's strategy to enhance liquidity and may also be used to reduce 2028 notes when the call premium declines in July, building on a previous $405 million notes issuance in January 2026.
(CLMT) Movement as an Input in Quant Signal Sets
This article provides an in-depth quantitative analysis of Calumet Specialty Products Partners L.p. (NASDAQ: CLMT), highlighting strong near-term sentiment with a long-term positive bias. It presents three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for various risk profiles, along with multi-timeframe signal analysis indicating support and resistance levels. The report emphasizes the absence of clear price positioning signals and elevated downside risk due to a lack of additional long-term support signals.
X3Q Stock Price and Chart — DUS:X3Q
This page provides detailed financial information for Calumet, Inc. (DUS:X3Q) including its stock price chart, key statistics, upcoming earnings dates, and analyst ratings. It highlights the company's segments in specialty products and renewables, its revenue, net income, and market capitalization, along with various trading ideas and ETFs holding the stock.
Calumet plans $150M 9.75% debt sale to repay credit line
Calumet announced a private placement of an additional $150 million of 9.75% Senior Notes due 2031, which will form a single series with existing notes, bringing the total to $555 million. The net proceeds are intended to repay outstanding borrowings under the company's revolving credit facility. This move continues Calumet's strategy of using private placements to refinance and extend debt maturities, aiming to reduce short-term secured borrowings despite increasing fixed interest obligations.
Calumet stock hits 52-week high at $31.41 amid strong performance
Calumet Specialty Products Partners, L.P. (CLMT) stock reached a new 52-week high of $31.41, reflecting a 145% increase over the past year. Despite this strong market performance, an InvestingPro analysis suggests the stock is currently overvalued and the company remains unprofitable with an EPS of -$0.39. Recent Q4 2025 earnings missed EPS forecasts but exceeded revenue expectations, and the company completed a $150 million private placement of senior notes.
Calumet stock hits 52-week high at $31.41 amid strong performance
Calumet Specialty Products Partners, L.P. (CLMT) stock reached a new 52-week high of $31.41, reflecting a 145% increase over the past year. Despite this strong market performance and investor confidence, InvestingPro analysis suggests the stock is currently overvalued and the company remains unprofitable with an EPS of -$0.39. Recent financial news for Calumet includes missing Q4 2025 EPS estimates while slightly exceeding revenue expectations, completing a $150 million private placement of Senior Notes, and announcing a board member's retirement.
Calumet (CLMT) Board Member Jennifer Straumins to Retire by 2026
Calumet Specialty Products Partners, L.P. (CLMT) announced that Board member Jennifer Straumins will retire at the 2026 Annual Meeting of Stockholders, having served on the Board since July 2024 and previously with Calumet GP, LLC. The company, which operates in the Basic Materials sector producing specialty and fuel-related products, faces significant financial challenges including negative revenue growth, a negative net margin, and a distressed Altman Z-Score, indicating potential bankruptcy risk. Despite its market presence, high leverage and declining revenue suggest a need for strategic improvements to enhance its financial health and market position.
Calumet Specialty Products Partners Announces Board Member Will Not Seek Re-Election in 2026
Calumet Specialty Products Partners, L.P. announced that one of its board members will not seek re-election at the end of their current term, a decision disclosed on March 25, 2026. The company did not provide reasons for the departure or details about potential replacements. This development occurs as Calumet continues its operations in specialty products and refining, with no further updates on board composition or governance impacts.
Calumet Specialty Prods stock faces headwinds amid fuel segment challenges and strategic shifts
Calumet Specialty Products Partners is struggling with declining fuel margins and production issues, forcing a strategic shift towards sustainable aviation fuel (SAF) and specialty lubricants. While the fuel segment faces headwinds with production halts and compressed crack spreads, the company's specialty products division shows stability. Investors are watching its sustainability efforts and debt management closely, as high leverage and suspended distributions present challenges despite potential long-term benefits from decarbonization trends.
Calumet Specialty Prods stock faces headwinds amid fuel segment challenges and strategic shifts
Calumet Specialty Products is facing challenges in its fuel segment due to declining margins and production issues, prompting a strategic shift towards specialty products and sustainable aviation fuel (SAF). The company's Great Falls facility is now producing SAF, and its specialty products division continues to provide stability. Investors are closely watching Calumet's debt management and its transition efforts amidst market volatility.
Calumet raises $150M through senior notes offering By Investing.com
Calumet, Inc. has successfully completed a private placement, raising $150 million through 9.75% Senior Notes due 2031, with net proceeds of approximately $154.9 million after expenses. This offering follows an earlier issuance and aims to repay outstanding borrowings under its revolving credit facility and reduce 2028 notes. Despite a surging stock price, Calumet remains unprofitable, and its stock is considered overvalued according to InvestingPro analysis, while the company also reported an EPS miss in its latest earnings.
